Fifty-five patients were included in this study, which assesses 18F-FDG PET/CT in small cell lung cancer (SCLC) staging and metabolic (SUVmax, MTV and TLG) and morphologic (CTvol) variables as predictors for overall survival (OS) and progression-free survival (PFS).

Key Points:

• Identifying variables that predict the prognosis of patients with SCLC is important.

• 18F-FDG PET/CT influences staging of patients with SCLC.

• Metabolic parameters could be used as predictors for PFS and OS.

Article: The Role of 18F-FDG PET/CT on Staging and Prognosis in Patients with Small Cell Lung Cancer

Authors: A. Zer, L. Domachevsky, Y. Rapson et al.